Takuya Tsujino

2.8k total citations
67 papers, 1.8k citations indexed

About

Takuya Tsujino is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Takuya Tsujino has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 26 papers in Oncology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Takuya Tsujino's work include Bladder and Urothelial Cancer Treatments (12 papers), Renal cell carcinoma treatment (8 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Takuya Tsujino is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Renal cell carcinoma treatment (8 papers) and Pancreatic and Hepatic Oncology Research (8 papers). Takuya Tsujino collaborates with scholars based in Japan, United States and United Kingdom. Takuya Tsujino's co-authors include Hiroyuki Isayama, Naoki Sasahira, Yousuke Nakai, Masao Omata, Hirofumi Kogure, Minoru Tada, Kazumasa Komura, Haruhito Azuma, Takeshi Kawabe and Teruo Inamoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Takuya Tsujino

61 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuya Tsujino Japan 23 646 584 417 374 360 67 1.8k
Alexandre Vasiljevic France 29 506 0.8× 697 1.2× 187 0.4× 187 0.5× 416 1.2× 119 2.8k
Qihui Zhai United States 23 596 0.9× 401 0.7× 441 1.1× 272 0.7× 517 1.4× 69 1.6k
Božo Krušlin Croatia 24 689 1.1× 446 0.8× 444 1.1× 273 0.7× 488 1.4× 158 1.7k
O. Roche France 26 714 1.1× 532 0.9× 217 0.5× 312 0.8× 179 0.5× 85 1.9k
Rebecca A. Gladdy Canada 21 337 0.5× 233 0.4× 682 1.6× 173 0.5× 854 2.4× 71 1.7k
Ho Jun Seol South Korea 28 621 1.0× 670 1.1× 523 1.3× 429 1.1× 607 1.7× 148 3.1k
Satyajit Karnik United States 12 844 1.3× 713 1.2× 251 0.6× 133 0.4× 312 0.9× 15 2.0k
T Nagasaka Japan 24 350 0.5× 411 0.7× 406 1.0× 114 0.3× 347 1.0× 48 1.6k
Laura Papi Italy 25 1.2k 1.8× 610 1.0× 766 1.8× 374 1.0× 292 0.8× 68 3.2k
Yucheng Yao United States 25 898 1.4× 314 0.5× 145 0.3× 196 0.5× 283 0.8× 56 2.1k

Countries citing papers authored by Takuya Tsujino

Since Specialization
Citations

This map shows the geographic impact of Takuya Tsujino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Tsujino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Tsujino more than expected).

Fields of papers citing papers by Takuya Tsujino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Tsujino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Tsujino. The network helps show where Takuya Tsujino may publish in the future.

Co-authorship network of co-authors of Takuya Tsujino

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Tsujino. A scholar is included among the top collaborators of Takuya Tsujino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Tsujino. Takuya Tsujino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gui, Fu, Baishan Jiang, Jie Jiang, et al.. (2025). Acute BRCAness induction and AR pathway blockage through CDK12/7/9 degradation enhances PARP inhibitor sensitivity in prostate cancer. Science Advances. 11(17). eadu0847–eadu0847. 2 indexed citations
3.
Takahara, Kiyoshi, Wataru Fukuokaya, Keiichiro Mori, et al.. (2025). Role of Cytoreductive Nephrectomy in the Immune Checkpoint Inhibitor Era: A Multicenter Collaborative Study. International Journal of Urology. 32(11). 1677–1685.
4.
Hashimoto, Mamoru, Kohei Taniguchi, Takafumi Minami, et al.. (2025). Cancer-induced Pain Is Associated With Poor Overall Survival of Urothelial Carcinoma Patients Treated With Enfortumab Vedotin. In Vivo. 39(3). 1533–1539. 1 indexed citations
5.
Hirasawa, Yosuke, Takeshi Hashimoto, Wataru Fukuokaya, et al.. (2024). Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan. Journal of Cancer Research and Clinical Oncology. 150(4). 182–182. 12 indexed citations
6.
Yamamoto, Yutaka, Mamoru Hashimoto, Takafumi Minami, et al.. (2024). Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor. International Journal of Clinical Oncology. 29(12). 1946–1958. 1 indexed citations
7.
Nishimura, Kazuki, Kiyoshi Takahara, Kazumasa Komura, et al.. (2024). Mechanistic insights into lethal hyper progressive disease induced by PD-L1 inhibitor in metastatic urothelial carcinoma. npj Precision Oncology. 8(1). 206–206.
8.
Fukuokaya, Wataru, Kazumasa Komura, Taizo Uchimoto, et al.. (2023). Real world evidence of enfortumab vedotin in patients with advanced urothelial cancer: A multicenter observational study. International Journal of Urology. 31(4). 342–347. 16 indexed citations
9.
Miao, Chenkui, Takuya Tsujino, Tomoaki Takai, et al.. (2022). RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. Science Advances. 8(7). eabl9794–eabl9794. 25 indexed citations
10.
Komura, Kazumasa, Teruo Inamoto, Takuya Tsujino, et al.. (2021). Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents. Oncogene. 40(43). 6210–6222. 19 indexed citations
11.
Inamoto, Teruo, Naoto Sassa, Ryohei Hattori, et al.. (2019). Influence of the Body Mass Index and its Effect on Tumor Characteristics and Survival among a Population with Access to Surgical Management of Upper Tract Urothelial Carcinoma. Current Urology. 12(4). 201–209. 4 indexed citations
12.
Tsujino, Takuya, Kazumasa Komura, Tomohisa Matsunaga, et al.. (2017). Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy. Annals of Surgical Oncology. 24(9). 2787–2793. 23 indexed citations
13.
Takahara, Kiyoshi, Masaaki Ii, Teruo Inamoto, et al.. (2016). microRNA-145 Mediates the Inhibitory Effect of Adipose Tissue-Derived Stromal Cells on Prostate Cancer. Stem Cells and Development. 25(17). 1290–1298. 103 indexed citations
14.
Fujii, Kenichi, Daizo Kawasaki, Hirokuni Akahori, et al.. (2010). Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart. 97(12). 977–982. 24 indexed citations
15.
Nakai, Yousuke, Hiroyuki Isayama, Hideaki Ijichi, et al.. (2010). Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine. British Journal of Cancer. 103(11). 1644–1648. 140 indexed citations
16.
Hirano, Keiichi, Minoru Tada, Naoki Sasahira, et al.. (2009). Correction. Gut. 58(7). 1032.2–1032. 1 indexed citations
17.
Takeuchi, Kyousuke, Takuya Tsujino, Maki Sugimoto, Shigeki Yoshida, & Sohei Kitazawa. (2008). Endocervical adenocarcinoma associated with lobular endocervical glandular hyperplasia showing rapid reaccumulation of hydrometra. International Journal of Gynecological Cancer. 18(6). 1285–1288. 8 indexed citations
18.
Matsubara, Saburo, Toshihiko Arizumi, Osamu Togawa, et al.. (2007). Endoscopic transpapillary approach to the gallbladder for diagnosing gallbladder cancer.. PubMed. 21(12). 809–13. 3 indexed citations
19.
Kogure, Hirofumi, Takuya Tsujino, Hiroshi Yagioka, et al.. (2007). Self-expandable metallic stents for malignant biliary obstruction with an anomalous pancreaticobiliary junction. Surgical Endoscopy. 22(3). 787–791. 2 indexed citations
20.
Hirano, Kenji, Takeshi Kawabe, Yutaka Komatsu, et al.. (2005). High‐rate pulmonary involvement in autoimmune pancreatitis. Internal Medicine Journal. 36(1). 58–61. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandre Vasiljevic Breakdown of academic impact, for papers by Qihui Zhai Breakdown of academic impact, for papers by Božo Krušlin Breakdown of academic impact, for papers by O. Roche Breakdown of academic impact, for papers by Rebecca A. Gladdy Breakdown of academic impact, for papers by Ho Jun Seol Breakdown of academic impact, for papers by Satyajit Karnik Breakdown of academic impact, for papers by T Nagasaka Breakdown of academic impact, for papers by Laura Papi Breakdown of academic impact, for papers by Yucheng Yao
Rankless by CCL
2026